TY - JOUR
T1 - Blood loss during radical prostatectomy
T2 - Impact on clinical, oncological and functional outcomes and complication rates
AU - Djavan, Bob
AU - Agalliu, Ilir
AU - Laze, Juliana
AU - Sadri, Helen
AU - Kazzazi, Amir
AU - Lepor, Herbert
PY - 2012/7/1
Y1 - 2012/7/1
N2 - OBJECTIVE: • To determine the short- and long-term impact of blood loss (BL) on clinical, oncological and functional outcomes as well as complication rates after an open radical retropubic prostatectomy (ORRP). PATIENTS AND METHODS: • Between 2000 and 2008, 1567 men who underwent an ORRP participated in our prospective longitudinal outcomes study. • Haematocrit (Hct) levels, transfusion rates, BL and complications were recorded prospectively. • Validated, self-administered quality-of-life (QoL) questionnaires were completed at baseline, 3, 6 and 12 months and yearly thereafter. • Urinary function and erectile dysfunction were assessed using AUA Symptom Score and the UCLA Prostate Cancer Index and analysis of variance ( ANOVA )/chi-square tests were used to compare clinical, BL, biochemical recurrence (BCR) and QoL outcomes amongst the three groups for continuous/categorical variables. RESULTS: • The mean estimated BL was 742.7 (45 to 3500) mL and 5.4% and 3.8% received an autologous (AU) or allogeneic (AL) blood transfusions, respectively. • The average baseline, induction, postoperative and discharge Hct was 43.8%, 48.3%, 35.7% and 34.1%, respectively. • The estimated BL and the rate of change of Hct correlated moderately ( r = 0.41, P < 0.0001). • Tertiles of BL were based on the difference between induction and discharge Hct (Delta 1) and the average Delta 1 for Groups 1, 2 and 3 were 7.9%, 12.7% and 17.2%, respectively. • Intra-operative, early/delayed complications, length of hospital stay (LoS), SM surgical margins status, anastomotic stricture and BCR were not statistically different ( P < 0.001) and the mean AUASS, UCLA Prostate Cancer urinary bother scores, urinary function scores, sexual bother/function scores at 24 months were similar amongst all tertiles ( P > 0.05). CONCLUSIONS: • BL during ORRP does not adversely impact clinical and functional outcomes irrespective of how BL is defi ned. • Thus, the lower BL associated with robotic-assisted laparoscopic prostatectomy (RALP) in and of itself would not be expected to improve functional or oncological outcomes.
AB - OBJECTIVE: • To determine the short- and long-term impact of blood loss (BL) on clinical, oncological and functional outcomes as well as complication rates after an open radical retropubic prostatectomy (ORRP). PATIENTS AND METHODS: • Between 2000 and 2008, 1567 men who underwent an ORRP participated in our prospective longitudinal outcomes study. • Haematocrit (Hct) levels, transfusion rates, BL and complications were recorded prospectively. • Validated, self-administered quality-of-life (QoL) questionnaires were completed at baseline, 3, 6 and 12 months and yearly thereafter. • Urinary function and erectile dysfunction were assessed using AUA Symptom Score and the UCLA Prostate Cancer Index and analysis of variance ( ANOVA )/chi-square tests were used to compare clinical, BL, biochemical recurrence (BCR) and QoL outcomes amongst the three groups for continuous/categorical variables. RESULTS: • The mean estimated BL was 742.7 (45 to 3500) mL and 5.4% and 3.8% received an autologous (AU) or allogeneic (AL) blood transfusions, respectively. • The average baseline, induction, postoperative and discharge Hct was 43.8%, 48.3%, 35.7% and 34.1%, respectively. • The estimated BL and the rate of change of Hct correlated moderately ( r = 0.41, P < 0.0001). • Tertiles of BL were based on the difference between induction and discharge Hct (Delta 1) and the average Delta 1 for Groups 1, 2 and 3 were 7.9%, 12.7% and 17.2%, respectively. • Intra-operative, early/delayed complications, length of hospital stay (LoS), SM surgical margins status, anastomotic stricture and BCR were not statistically different ( P < 0.001) and the mean AUASS, UCLA Prostate Cancer urinary bother scores, urinary function scores, sexual bother/function scores at 24 months were similar amongst all tertiles ( P > 0.05). CONCLUSIONS: • BL during ORRP does not adversely impact clinical and functional outcomes irrespective of how BL is defi ned. • Thus, the lower BL associated with robotic-assisted laparoscopic prostatectomy (RALP) in and of itself would not be expected to improve functional or oncological outcomes.
KW - Blood loss
KW - Clinical outcomes
KW - Complication rates
KW - Functional outcomes
KW - Oncological outcomes
KW - Radical prostatectomy
UR - http://www.scopus.com/inward/record.url?scp=84862295163&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862295163&partnerID=8YFLogxK
U2 - 10.1111/j.1464-410X.2011.10812.x
DO - 10.1111/j.1464-410X.2011.10812.x
M3 - Article
C2 - 22145995
AN - SCOPUS:84862295163
SN - 1464-4096
VL - 110
SP - 69
EP - 75
JO - British Journal of Urology
JF - British Journal of Urology
IS - 1
ER -
